Table II.

Phenotype of graft-infiltrating leukocytes in T-bet−/− recipients with and without IL-17 neutralization

Infiltrating cells
T-bet−/− control Ig (day 14)
T-bet−/− IL-17 neutralization (day 14)
T-bet−/− IL-17 neutralization (day 40)
Lymphocytes 15.4 ± 2.1 3.2 ± 1.3 10.3 ± 3 
Macrophages 21.6 ± 4.3 4.7 ± 1.8 13.6 ± 3 
Neutrophils 18.4 ± 5.6 1.2 ± 0.3 4.6 ± 1.9 
Eosinophils 96.1 ± 13.5 26.4 ± 6.5 71.7 ± 7.9 
Total 151.1 ± 18.3 34.1 ± 6.9 100.3 ± 13.7 
Infiltrating cells
T-bet−/− control Ig (day 14)
T-bet−/− IL-17 neutralization (day 14)
T-bet−/− IL-17 neutralization (day 40)
Lymphocytes 15.4 ± 2.1 3.2 ± 1.3 10.3 ± 3 
Macrophages 21.6 ± 4.3 4.7 ± 1.8 13.6 ± 3 
Neutrophils 18.4 ± 5.6 1.2 ± 0.3 4.6 ± 1.9 
Eosinophils 96.1 ± 13.5 26.4 ± 6.5 71.7 ± 7.9 
Total 151.1 ± 18.3 34.1 ± 6.9 100.3 ± 13.7 

Five high-power fields were counted per slide, with one slide each from three to four heart grafts per group. Results are presented as mean numbers of cells ± SD.

or Create an Account

Close Modal
Close Modal